SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-106023
Filing Date
2007-05-08
Accepted
2007-05-08 16:09:22
Documents
7
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT d10q.htm 10-Q 243392
2 COLLABORATION AND LICENSE AGREEMENT dex101.htm EX-10.1 376411
3 COLLABORATION AGREEMENT BETWEEN SEATTLE GENETICS, INC. AND GENENTECH, INC. dex102.htm EX-10.2 278656
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9132
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9133
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4156
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4155
  Complete submission text file 0001193125-07-106023.txt   926473
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32405 | Film No.: 07828325
SIC: 2836 Biological Products, (No Diagnostic Substances)